Your browser doesn't support javascript.
loading
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli, Julien; Meziani, Ferhat; Dellamonica, Jean; Cordier, Pierre-Yves; Allardet-Servent, Jerome; Fraisse, Megan; Velly, Lionel; Barbar, Saber Davide; Lehingue, Samuel; Guervilly, Christophe; Desgrouas, Maxime; Camou, Fabrice; Piperoglou, Christelle; Vely, Frederic; Demaria, Olivier; Karakunnel, Joyson; Fares, Joanna; Batista, Luciana; Rotolo, Federico; Viotti, Julien; Boyer-Chammard, Agnes; Lacombe, Karine; Le Dault, Erwan; Carles, Michel; Schleinitz, Nicolas; Vivier, Eric.
Afiliação
  • Carvelli J; AP-HM, Department of Intensive Care, Réanimation des Urgences, Medecine Intensive & Reanimation, Timone University Hospital, Marseille, France.
  • Meziani F; Marseille Immunopôle, Timone University Hospital, CNRS, INSERM, CIML, Marseille, France.
  • Dellamonica J; Aix-Marseille University, Marseille, France.
  • Cordier PY; Department of Intensive Care, Médecine Intensive & Réanimation, Nouvel Hôpital Civil, Strasbourg University Hospital, INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS (Fédération de Médecine Translationnelle de Strasbourg), Strasb
  • Allardet-Servent J; Department of Intensive Care, Medecine Intensive & Reanimation, Hôpital l'Archet 1, Nice University Hospital, Cote d'Azur University, UR2CA, Nice, France.
  • Fraisse M; Department of Intensive Care, Réanimation Polyvalente, HIA Laveran, Marseille, France.
  • Velly L; Department of Intensive Care, Hôpital Européen, Marseille, France.
  • Barbar SD; Department of Intensive Care, Réanimation Polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France.
  • Lehingue S; AP-HM, Department of Anesthesiology & Critical Care Medicine, Réanimation Polyvalente, Timone University Hospital, Institut Neuroscience Timone CNRS UMR-7289, Marseille, France.
  • Guervilly C; Department of Intensive Care, Nîmes University Hospital, University of Montpellier, Nîmes, France.
  • Desgrouas M; Department of Intensive Care, Hôpital Saint-Joseph, Marseille, France.
  • Camou F; AP-HM, Department of Intensive Care, Médecine Intensive Réanimation, North Hospital, Centre d'Etudes et de Recherches sur les Services de Santé et qualité de vie EA 3279Marseille, Marseille, France.
  • Piperoglou C; Department of Intensive Care, Medecine Intensive & Reanimation, Centre Hospitalier Régional d'Orléans, Orléans, France.
  • Vely F; Department of Intensive Care, Bordeaux University Hospital, Hôpital Saint-André, University of Bordeaux, Bordeaux, France.
  • Demaria O; AP-HM, Timone University Hospital, Immunology, Marseille, France.
  • Karakunnel J; Innate Pharma, Marseille, France.
  • Fares J; AP-HP, Tropical Medicine & Infectious Diseases, Saint-Antoine Univeristy Hospital, Sorbonne University, Inserm UMR-S1136 IPLESP, Paris, France.
  • Batista L; Tropical Medicine & Infectious Diseases, HIA Laveran, Marseille, France.
  • Rotolo F; Tropical Medicine & Infectious Diseases, Hôpital l'Archet 1, Nice Univeristy Hospital, Université Côte d'Azur, Inserm-C3M, Nice, France.
  • Viotti J; AP-HM, Internal Medicine Department, Timone University Hospital, Marseille, France.
  • Boyer-Chammard A; Department of Intensive Care, Médecine Intensive & Réanimation, Nouvel Hôpital Civil, Strasbourg University Hospital, INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS (Fédération de Médecine Translationnelle de Strasbourg), Strasb
  • Lacombe K; Department of Intensive Care, Medecine Intensive & Reanimation, Hôpital l'Archet 1, Nice University Hospital, Cote d'Azur University, UR2CA, Nice, France.
  • Le Dault E; Department of Intensive Care, Réanimation Polyvalente, HIA Laveran, Marseille, France.
  • Carles M; Department of Intensive Care, Hôpital Européen, Marseille, France.
  • Schleinitz N; Department of Intensive Care, Réanimation Polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France.
  • Vivier E; Aix-Marseille University, Marseille, France.
Crit Care Med ; 50(12): 1788-1798, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36218354
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article